首页> 外文期刊>Indian drugs >POLYMORPHIC STUDIES OF FLUCONAZOLE IN DIFFERENT CRYSTAL SOLVATE FORMS AND ITS IMPLICATION ON BCS SOLUBILITY AND DISSOLUTION
【24h】

POLYMORPHIC STUDIES OF FLUCONAZOLE IN DIFFERENT CRYSTAL SOLVATE FORMS AND ITS IMPLICATION ON BCS SOLUBILITY AND DISSOLUTION

机译:不同晶体溶剂化物形式氟康唑的多态性研究及其对BCS溶解度和溶解的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Fluconazole (anhydrate) is an anti-fungal agent which exists in various polymorphic forms. The present study is an attempt to obtain crystal solvates of fluconazole using various solvents and study its effect on polymorphic transformation and its implication on solubility and dissolution, fluconazole exhibits polymorphism and is poorly soluble in water, hence attempt was made to improve its solubility and dissolution. Crystal solvates of fluconazole were prepared in different solvents viz acetonitrile, methanol, propan-2-d and n-butanol. Polymorphic transformations were ascertained by subjecting the crystal solvates of fluconazole to BCS solubility, dissolution, FTIR, optical microscopy, DSC, SEM and X-ray powder diffraction (XRPD). Results indicated that the crystal solvates of propan-2-ol exhibited improved solubility and dissolution compared to other crystal solvates and pure drug. BCS based intrinsic solubility studies revealed that crystal solvates of propan-2-ol exhibited highest solubility at pH 1.2. FTIR studies revealed that the functional groups of fluconazole were found to be unaltered. Optical microscopy and scanning electron microscopy studies revealed morphological changes of crystal solvates, which indicates polymorphic changes of fluconazole. DSC of crystal solvates obtained from propan-2-ol revealed change to hydrate form, whereas XRPD study revealed crystal solvates of propan-2-ol were more crystalline in nature when compared with that of the pure drug.
机译:氟康唑(无水化)是一种以各种多态性形式存在的抗真菌剂。本研究是试图使用各种溶剂获得氟康唑的晶体溶剂,并研究其对多态性转化的影响及其对溶解度和溶解的影响,氟康唑表现出多态性并易溶于水,因此尝试改善其溶解度和溶解。 。在不同的溶剂VIZ乙腈,甲醇,丙-2-D和正丁醇中制备氟康唑的晶体溶剂化物。通过使氟康唑的晶体溶剂对BCS溶解度,溶解,FTIR,光学显微镜,DSC,SEM和X射线粉末衍射(XRPD)进行多态性转化来确定多态性转化。结果表明,与其他晶体溶剂化物和纯药物相比,丙烷-2-OL的晶体溶剂化提高了溶解度和溶解。基于BCS的内在溶解度研究表明,丙烷-2-OL的晶体溶剂化物在pH 1.2时表现出最高的溶解度。 FTIR的研究表明,发现氟康唑的官能团被淘汰。光学显微镜和扫描电子显微镜研究显示了晶体溶剂化物的形态变化,表明氟康唑的多态变化。从Propan-2-Ol获得的晶体溶剂化物的DSC显示出水合物形式的变化,而XRPD研究显示与纯药物相比,丙普-2-醇的丙烷-2-醇的晶体溶剂含量更结晶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号